Ramiro Garzon is a Hematology physician affiliated with University of Utah. OpenAlex indexes 362 publications with 24,786 citations (h-index 60). By OpenAlex citation count, this profile ranks in the top 10% of Hematology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1950 Circle Of Hope Dr # 4126
Salt Lake City, UT 841125500
Telephone
801-581-2121Provider last certified this registry record 3 Dec 2022.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
29.8%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor29.8%Acyclovir100%Part D<11 patientsAnti-infectives
28.1%Fluoroquinolone Antibacterial28.1%Levofloxacin100%Part D<11 patientsMusculoskeletal
17.5%Xanthine oxidase inhibitor17.5%Allopurinol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2023–2025 per NIH RePORTER. The latest:
- Developing novel therapies to improve blood stem cell transplantation outcomes
Utah State Higher Education System--University of Utah
FY2025$630,428R01HL163849 - Biology and Targeting of noncoding RNAs in AML
Utah State Higher Education System--University of Utah
FY2025$352,275R01CA240612 - Developing novel therapies to improve blood stem cell transplantation outcomes
University of Utah
FY2024$620,713R01HL163849
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Colman, MD
University of Utah
Michael Varner, MD
University of Utah
James Fang
University of Utah
Wallace Akerley, MD
University of Utah
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”